COVID-19 Vaccine Storage: Addressing the Challenges of mRNA-Based Vaccine Storage at Ultra-Low Temperatures, Upcoming Webinar Hosted by Xtalks
In this free webinar, the featured speakers will discuss critical factors to consider for proper vaccine storage in a new era of vaccine challenges. Attendees will learn about key decision points when choosing proper equipment for storing the upcoming COVID-19 vaccine and understand what differentiates high-performance, purpose-built vaccine equipment from the rest.
TORONTO, Jan. 8, 2021 /PRNewswire-PRWeb/ -- mRNA vaccine research conducted prior to COVID-19's arrival allowed scientists to devise mechanisms to stably deliver mRNA molecules into cells, once injected with a syringe. Compared to traditional vaccine development, mRNA vaccines are relatively simple to design and manufacture. This made them leading candidates in the urgent race for a COVID-19 vaccine. However, maintaining mRNA stability while outside our bodies presents a multitude of logistical hurdles, each requiring careful attention.
RNA utilized in research and clinical laboratories is traditionally stored in -80°C freezers. These ultra-low temperatures (ULT) cease molecular movement and enzyme activity in mRNA samples, preserving their structure and function for many years. An ultra-low temperature freezer is a staple in every life science laboratory, but in clinics and hospitals where conventional vaccines are stored at 5°C, specialized freezers do not exist. To add to the complexity, two leading mRNA vaccine manufacturers will require two separate temperature storage points (-20°C and -80°C), requiring separate, specialized units.
Vaccine administration sites must quickly equip their facilities with new cold storage equipment. The inability of an ultra-low temperature freezer to provide stable temperatures at a -80°C setpoint may compromise the vaccine's viability, leading to improper immunization of the public. A critical balance of low energy consumption, longevity, and temperature performance make for the best COVID-19 vaccine ULT freezer.
Join featured speakers from PHCNA, Carl Radosevich, Senior Manager, Scientific Applications & Collaborations; and Joe LaPorte, Director, Projects and Regulatory, in a live webinar on Tuesday, January 19, 2021 at 1pm EST.
For more information, or to register for this event, visit COVID-19 Vaccine Storage: Addressing the Challenges of mRNA-Based Vaccine Storage at Ultra-Low Temperatures.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Media Contact
Sydney Perelmutter, Xtalks, +1 (416) 977-6555 x 352, [email protected]
SOURCE Xtalks
Share this article